对阿里雷扎·戈雷菲和胡曼·贾拉达特致编辑的信的回复：关于丹尼尔·D·夏皮罗、何塞·A·卡拉姆、洛根·曾普等人的《免疫检查点抑制剂治疗后减瘤性肾切除术安全且有助于无治疗间期》。《欧洲泌尿外科开放科学》2023年；50:43 - 6。 - Suppr

Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re: Daniel D. Shapiro, Jose A. Karam, Logan Zemp, et al. Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals. Eur Urol Open Sci 2023;50:43-6.

作者信息

Shapiro Daniel D, Karam Jose A, Master Viraj A, Zemp Logan W, Sexton Wade J, Matin Surena F, Spiess Philippe E, Jason Abel E

机构信息

Department of Urology, The University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.

Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

出版信息

Eur Urol. 2023 Aug;84(2):e55-e56. doi: 10.1016/j.eururo.2023.04.023. Epub 2023 May 5.

DOI:10.1016/j.eururo.2023.04.023

PMID:37149462

Abstract

摘要

相似文献

Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re: Daniel D. Shapiro, Jose A. Karam, Logan Zemp, et al. Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals. Eur Urol Open Sci 2023;50:43-6.对阿里雷扎·戈雷菲和胡曼·贾拉达特致编辑的信的回复：关于丹尼尔·D·夏皮罗、何塞·A·卡拉姆、洛根·曾普等人的《免疫检查点抑制剂治疗后减瘤性肾切除术安全且有助于无治疗间期》。《欧洲泌尿外科开放科学》2023年；50:43 - 6。

Eur Urol. 2023 Aug;84(2):e55-e56. doi: 10.1016/j.eururo.2023.04.023. Epub 2023 May 5.

Re: Daniel D. Shapiro, Jose A. Karam, Logan Zemp, et al. Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals. Eur Urol Open Sci 2023;50:43-6.回复：丹尼尔·D·夏皮罗、何塞·A·卡拉姆、洛根·曾普等。免疫检查点抑制剂治疗后减瘤性肾切除术安全且有助于延长无治疗间期。《欧洲泌尿外科开放科学》2023年；50卷：43 - 6页

Eur Urol. 2023 Aug;84(2):e53-e54. doi: 10.1016/j.eururo.2023.03.042. Epub 2023 May 5.

Reply to Daniel D. Shapiro, Jose A. Karam, Viraj A. Master, et al.'s Letter to the Editor re: Wesley Yip, Alireza Ghoreifi, Thomas Gerald, et al. Perioperative Complications and Oncologic Outcomes of Nephrectomy Following Immune Checkpoint Inhibitor Therapy: A Multicenter Collaborative Study. Eur Urol Oncol. Eur Urol. Onc. 2023;604-610.对丹尼尔·D·夏皮罗、何塞·A·卡拉姆、维拉杰·A·马斯特等人致编辑信的回复，信的主题为：韦斯利·叶、阿里雷扎·戈雷菲、托马斯·杰拉尔德等人。免疫检查点抑制剂治疗后肾切除术的围手术期并发症和肿瘤学结局：一项多中心合作研究。《欧洲泌尿外科肿瘤学》。《欧洲泌尿外科》。肿瘤学。2023年；604 - 610页。

Eur Urol Oncol. 2023 Dec;6(6):637. doi: 10.1016/j.euo.2023.05.010. Epub 2023 Jun 12.

Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re: Fredrik Liedberg, Petter Kollberg, Marie Allerbo, et al. Preventing Parastomal Hernia After Ileal Conduit by the Use of a Prophylactic Mesh: A Randomised Study. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.033.

Eur Urol. 2020 Nov;78(5):e186-e187. doi: 10.1016/j.eururo.2020.09.025. Epub 2020 Sep 17.

Re: Wesley Yip, Alireza Ghoreifi, Thomas Gerald, et al. Perioperative Complications and Oncologic Outcomes of Nephrectomy Following Immune Checkpoint Inhibitor Therapy: A Multicenter Collaborative Study. Eur Urol Oncol. Eur Urol. Onc. 2023;604-610.回复：韦斯利·叶、阿里雷扎·戈雷菲、托马斯·杰拉尔德等。免疫检查点抑制剂治疗后肾切除术的围手术期并发症和肿瘤学结果：一项多中心合作研究。《欧洲泌尿外科肿瘤学》。《欧洲泌尿外科》肿瘤学。2023年；604 - 610页。

Eur Urol Oncol. 2023 Dec;6(6):638-639. doi: 10.1016/j.euo.2023.05.007. Epub 2023 Jun 1.

Re: Ziad Bakouny, Talal El Zarif, Shaan Dudani, et al. Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium. Eur Urol 2023;83:145-51.回复：齐亚德·巴库尼、塔拉勒·埃尔·扎里夫、沙恩·杜达尼等人。免疫检查点抑制剂或靶向治疗的转移性肾细胞癌的 upfront 减瘤性肾切除术：来自国际转移性肾细胞癌数据库联盟的一项观察性研究。《欧洲泌尿外科杂志》2023 年；83 卷：145 - 151 页。

Eur Urol. 2023 Sep;84(3):e75. doi: 10.1016/j.eururo.2023.04.040. Epub 2023 Jun 1.

Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re: Isamu Tachibana, Sean Q. Kern, Antoin Douglawi, et al. Primary Retroperitoneal Lymph Node Dissection for Patients with Pathologic Stage II Nonseminomatous Germ Cell Tumor-N1, N2, and N3 Disease: Is Adjuvant Chemotherapy Necessary? J Clin Oncol. In press. https://doi.org/10.1200/JCO.22.00118: Is Retroperitoneal Lymph Node Dissection Without Adjuvant Chemotherapy Enough for All Patients with Pathologic Stage II Nonseminoma Germ Cell Tumor?对阿里雷扎·戈雷菲和胡曼·贾拉达特致编辑的信的回复：关于立花勇、肖恩·Q·克恩、安托万·道格拉斯维等人的文章《病理II期非精原细胞性生殖细胞肿瘤-N1、N2和N3疾病患者的原发性腹膜后淋巴结清扫术：辅助化疗是否必要？》《临床肿瘤学杂志》即将发表。https://doi.org/10.1200/JCO.22.00118：对于所有病理II期非精原细胞瘤生殖细胞肿瘤患者，不进行辅助化疗的腹膜后淋巴结清扫术是否足够？

Eur Urol. 2023 Jan;83(1):e20-e21. doi: 10.1016/j.eururo.2022.09.018. Epub 2022 Oct 1.

Reply to Eduard Roussel, Riccardo Bertolo, Chiara Ciccarese, et al's Letter to the Editor re: E. Jason Abel, Viraj A. Master, Philippe E. Spiess, et al. The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic Features. Eur Urol Oncol. 2023;6:266-274.对爱德华·鲁塞尔、里卡尔多·贝尔托洛、基娅拉·奇卡雷塞等人致编辑的信的回复，信的主题为：E. 杰森·阿贝尔、维贾伊·A. 马斯特、菲利普·E. 斯皮斯等人的《减瘤性肾切除术（SCREEN）评分：通过整合常见影像学特征改善手术风险分层》。《欧洲泌尿外科肿瘤学》2023年；6卷：266 - 274页。

Eur Urol Oncol. 2024 Apr;7(2):302-303. doi: 10.1016/j.euo.2023.10.025. Epub 2023 Nov 23.

Reply to Nirmish Singla and Vitaly Margulis's Letter to the Editor re: Geraldine Pignot, Antoine Thiery-Vuillemin, Jochen Walz, et al. Nephrectomy After Complete Response to Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma: A New Surgical Challenge? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.12.018. The Next Surgical Frontier in Kidney Cancer: Nephrectomy After Immune Checkpoint Inhibition: Nephrectomy After Immunotherapy: The Duration of Treatment Exposure is Probably Decisive.回复尼米什·辛格拉和维塔利·马尔古利斯致编辑的信，信中涉及：杰拉尔丁·皮尼奥、安托万·蒂埃里 - 维勒明、约亨·瓦尔兹等人。转移性肾细胞癌对免疫检查点抑制剂完全缓解后的肾切除术：一项新的手术挑战？《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2019.12.018。肾癌的下一个手术前沿：免疫检查点抑制后的肾切除术：免疫治疗后的肾切除术：治疗暴露时间可能起决定性作用。

Eur Urol. 2020 Aug;78(2):e81-e82. doi: 10.1016/j.eururo.2020.04.052. Epub 2020 May 7.

Re: Bimal Bhindi, Jeffrey Graham, J. Connor Wells, et al. Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.04.038: Cytoreductive Nephrectomy: To Whom and When?回复：比马尔·宾迪、杰弗里·格雷厄姆、J·康纳·韦尔斯等人。初诊转移性肾细胞癌患者的延期减瘤性肾切除术。《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2020.04.038：减瘤性肾切除术：适用于谁以及何时进行？

Eur Urol Oncol. 2020 Aug;3(4):559-560. doi: 10.1016/j.euo.2020.05.011. Epub 2020 Jun 15.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re: Daniel D. Shapiro, Jose A. Karam, Logan Zemp, et al. Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals. Eur Urol Open Sci 2023;50:43-6.

作者信息

机构信息

出版信息

相似文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献